Marvin H Eng1, Pedro Villablanca2, Tiberio Frisoli2, Adam B Greenbaum3, William W O'Neill2. 1. Center for Structural Heart Disease, Structural Heart Disease Fellowship Director, Director of Research for the Center for Structural Heart Disease, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI, 48202, USA. Meng1@hfhs.org. 2. Center for Structural Heart Disease, Structural Heart Disease Fellowship Director, Director of Research for the Center for Structural Heart Disease, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI, 48202, USA. 3. Emory University, Atlanta, GA, USA.
Abstract
PURPOSE OF REVIEW: Examine the latest data and techniques regarding transcaval access and closure. RECENT FINDINGS: Transcaval access was proven to be a feasible and a translatable skill in a 100 patient open-label prospective study. No late complications from fistulas occurred and of all patients alive at 1 year, one fistula remained open. Transcaval is a viable access route for large bore devices. With adequate planning, bleeding and vascular complications are minimal. It should be integrated into the rubric of transcatheter large bore access.
PURPOSE OF REVIEW: Examine the latest data and techniques regarding transcaval access and closure. RECENT FINDINGS: Transcaval access was proven to be a feasible and a translatable skill in a 100 patient open-label prospective study. No late complications from fistulas occurred and of all patients alive at 1 year, one fistula remained open. Transcaval is a viable access route for large bore devices. With adequate planning, bleeding and vascular complications are minimal. It should be integrated into the rubric of transcatheter large bore access.
Entities:
Keywords:
Alternative access; Transcatheter aortic valve replacement; Transcaval
Authors: Adam B Greenbaum; Vasilis C Babaliaros; Marcus Y Chen; Annette M Stine; Toby Rogers; William W O'Neill; Gaetano Paone; Vinod H Thourani; Kamran I Muhammad; Robert A Leonardi; Stephen Ramee; James F Troendle; Robert J Lederman Journal: J Am Coll Cardiol Date: 2016-10-29 Impact factor: 24.094
Authors: Robert J Lederman; Vasilis C Babaliaros; Toby Rogers; Annette M Stine; Marcus Y Chen; Kamran I Muhammad; Robert A Leonardi; Gaetano Paone; Jaffar M Khan; Bradley G Leshnower; Vinod H Thourani; Xin Tian; Adam B Greenbaum Journal: JACC Cardiovasc Interv Date: 2019-03-11 Impact factor: 11.195
Authors: Robert J Lederman; Adam B Greenbaum; Toby Rogers; Jaffar M Khan; Melissa Fusari; Marcus Y Chen Journal: JACC Cardiovasc Interv Date: 2017-01-09 Impact factor: 11.195
Authors: Adam B Greenbaum; William W O'Neill; Gaetano Paone; Mayra E Guerrero; Janet F Wyman; R Lebron Cooper; Robert J Lederman Journal: J Am Coll Cardiol Date: 2014-05-07 Impact factor: 24.094
Authors: Jean-Michel Paradis; Hersh S Maniar; John M Lasala; Susheel Kodali; Mathew Williams; Brian R Lindman; Ralph J Damiano; Marc R Moon; Raj R Makkar; Vinod H Thourani; Vasilis Babaliaros; Ke Xu; Girma Minalu Ayele; Lars Svensson; Martin B Leon; Alan Zajarias Journal: JACC Cardiovasc Interv Date: 2015-09 Impact factor: 11.195
Authors: Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb Journal: N Engl J Med Date: 2016-04-02 Impact factor: 91.245